» Articles » PMID: 32582882

Medawar's Paradox and Immune Mechanisms of Fetomaternal Tolerance

Overview
Journal OBM Transplant
Date 2020 Jun 26
PMID 32582882
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Brazilian-born British biologist Dr. Peter Medawar played an integral role in developing the concepts of immunologic rejection and tolerance, which led to him receiving the Nobel Prize "for the discovery of acquired immunologic tolerance" and eventually made organ transplantation a reality. However, at the time of his early work in tolerance, a paradox to his theories was brought to his attention; how was pregnancy possible? Pregnancy resembles organ transplantation in that the fetus, possessing paternal antigens, is a semi-allogeneic graft that can survive without immunosuppression for 9 months. To answer this question, Medawar proposed three hypotheses of how a mother supports her fetus , now known as "Medawar's Paradox." The mechanisms that govern fetomaternal tolerance are still incompletely understood but may provide critical insight into how to achieve immune tolerance in organ transplantation. Here, we review current understanding of the immune factors responsible for fetomaternal tolerance during pregnancy and discuss the potential implications for advances in transplantation science.

Citing Articles

Changes in Immune Response during Pig Gestation with a Focus on Cytokines.

Velez C, Williamson D, Canovas M, Giai L, Rutland C, Perez W Vet Sci. 2024; 11(1).

PMID: 38275932 PMC: 10819333. DOI: 10.3390/vetsci11010050.


Fetal-maternal interactions during pregnancy: a 'three-in-one' perspective.

Zhang Y, Liu Z, Sun H Front Immunol. 2023; 14:1198430.

PMID: 37350956 PMC: 10282753. DOI: 10.3389/fimmu.2023.1198430.


Immune Response and Transplacental Antibody Transfer in Pregnant Women after COVID-19 Vaccination.

Lubrano C, Mancon A, Anelli G, Gagliardi G, Corneo R, Bianchi M J Pers Med. 2023; 13(4).

PMID: 37109075 PMC: 10141882. DOI: 10.3390/jpm13040689.


Synergies of Extracellular Vesicles and Microchimerism in Promoting Immunotolerance During Pregnancy.

Murrieta-Coxca J, Fuentes-Zacarias P, Ospina-Prieto S, Markert U, Morales-Prieto D Front Immunol. 2022; 13:837281.

PMID: 35844513 PMC: 9285877. DOI: 10.3389/fimmu.2022.837281.


Evolution of Placental Hormones: Implications for Animal Models.

Carter A Front Endocrinol (Lausanne). 2022; 13:891927.

PMID: 35692413 PMC: 9176407. DOI: 10.3389/fendo.2022.891927.


References
1.
Borzychowski A, Croy B, Chan W, Redman C, Sargent I . Changes in systemic type 1 and type 2 immunity in normal pregnancy and pre-eclampsia may be mediated by natural killer cells. Eur J Immunol. 2005; 35(10):3054-63. DOI: 10.1002/eji.200425929. View

2.
Rajagopalan S, Bryceson Y, Kuppusamy S, Geraghty D, van der Meer A, Joosten I . Activation of NK cells by an endocytosed receptor for soluble HLA-G. PLoS Biol. 2005; 4(1):e9. PMC: 1318474. DOI: 10.1371/journal.pbio.0040009. View

3.
Piccinni M, Giudizi M, Biagiotti R, Beloni L, Giannarini L, Sampognaro S . Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J Immunol. 1995; 155(1):128-33. View

4.
Ploegh H . Biosynthesis and assembly of MHC antigens. Scand J Rheumatol Suppl. 1990; 87:32-5. DOI: 10.3109/03009749009097055. View

5.
Peyman J, Hammond G . Localization of IFN-gamma receptor in first trimester placenta to trophoblasts but lack of stimulation of HLA-DRA, -DRB, or invariant chain mRNA expression by IFN-gamma. J Immunol. 1992; 149(8):2675-80. View